Figure 1 | Genetics in Medicine

Figure 1

From: The clinical utility of DNA-based screening for fetal aneuploidy by primary obstetrical care providers in the general pregnancy population

Figure 1

Weekly DNA First test enrollment of the five largest participating practices, expressed as a percentage of historical serum screening. Week of study enrollment (horizontal axis) versus weekly test volume (expressed as a percentage of serum screening volume in the previous 6 months). Practices A through C began enrolling soon after study initiation and exceeded historical screening rates by 30, 13, and 14% (horizontal dashed lines) by weeks 6, 3, and 13, respectively (vertical dashed lines). Practices D and E began enrollment later but matched historical rates quickly (at 16 and 20 weeks) and exceeded those rates by 40 and 8%, respectively.

Back to article page